# AM-101 in the Treatment of Acute Tinnitus 2

> **NCT01803646** · PHASE3 · COMPLETED · sponsor: **Auris Medical, Inc.** · enrollment: 343 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** AM-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01803646
- **Lead sponsor:** Auris Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 343 (ACTUAL)
- **Last updated:** 2018-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01803646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01803646, "AM-101 in the Treatment of Acute Tinnitus 2". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT01803646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*